The withdrawal comes after postmarketing studies showed that the risks of side effects were greater than the benefits.

Pfizer withdraws OXBRYTA after post marketing studies showed that the risks of side effects were greater than the benefits.

Pfizer withdrew its pill for sickle cell disease amid heightened European scrutiny, triggered by death rates seen in clinical ...

Current sickle cell disease treatment options include: A cornerstone of SCD treatment since 1988, hydroxyurea works by increasing the production of hemoglobin F, which helps prevent the formation of ...

Goldman Sachs analyst Mark Delaney has maintained their bullish stance on JBL stock, giving a Buy rating on September 27. Mark Delaney’s ...

Former PM Ehud Olmert confirms Israel's role in the 2008 killing of Hezbollah's Mughniyeh, breaking 16-year silence on covert Syria mission. The Mitvim Institute's 2024 Foreign Policy Index ...

Editorial writers explain these public health issues.

Meta Fined $102M for Storing Facebook Passwords in Plain Text ...

The Greek discovery of Iceland more than one thousand years prior to the Vikings is supported by evidence published recently in The Housman Society Journal. Based on an essentially linguistic ...

Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...